Drug Shortage Report for PMS-BRIMONIDINE

Last updated on 2020-04-02 History
Report ID 1774
Drug Identification Number 02246284
Brand name PMS-BRIMONIDINE
Common or Proper name Brimonidine
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5 ml & 10 ml
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2013-07-23
Estimated end date Unknown
Actual end date 2020-04-01
Shortage status Resolved
Updated date 2020-04-02
Company comments Product to be discontinued
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-04-02 French Compare
v3 2020-04-02 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 4 of 4